HEMATOLOGIC DISEASES
Clinical trials for HEMATOLOGIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR breakthrough trial aims to cure kids of lifelong blood disease
⭐️ CURE ⭐️ OngoingThis study is testing a one-time gene therapy called CTX001 in children with severe transfusion-dependent beta-thalassemia. Doctors use CRISPR gene-editing technology to modify a patient's own blood stem cells, then infuse them back, aiming to eliminate the need for lifelong bloo…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: ⭐️ CURE ⭐️
Last updated Mar 23, 2026 15:18 UTC
-
Trial for new bleeding disorder pill withdrawn before starting
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new oral drug called HMPL-523 for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing a risk of bleeding. The study was designed to enroll adults wh…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
CRISPR gene therapy patients monitored for years in groundbreaking study
Disease control ENROLLING_BY_INVITATIONThis study tracks the long-term safety and effectiveness of a one-time CRISPR gene therapy called CTX001 in people with sickle cell disease or beta-thalassemia. It follows 160 children and adults who have already received the therapy in earlier studies. The main goal is to monito…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New drug hope to stop dangerous transplant complication in kids
Disease control OngoingThis study is testing if adding a drug called vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults getting a bone marrow transplant for blood cancers. GVHD is a serious complication where the donor's immune cells atta…
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for intimacy after cancer treatment
Symptom relief OngoingThis study is testing a new support program designed to help adults who have had a stem cell transplant for blood cancer with sexual problems that are causing distress. About 120 participants will be randomly assigned to receive either this specialized program or standard educati…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Massive medical data hunt aims to unlock future cures
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect medical information from up to 10,000 patients and stem cell donors to help researchers learn more about a wide range of diseases and train future doctors. Participants' existing medical records, test results, and treatment data will be gathered over tw…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Could muscle strength predict survival after a stem cell transplant?
Knowledge-focused OngoingThis study aims to understand how muscle strength and body composition affect recovery and long-term health in people with blood cancers who receive a stem cell transplant. Researchers will observe 144 patients to see if their muscle health at the time of transplant can predict c…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Massive study tracks health of 32,000 gulf oil spill workers for a decade
Knowledge-focused OngoingThis study is tracking the long-term health of over 32,000 people who helped clean up the 2010 Deepwater Horizon oil spill or lived nearby. Researchers are comparing the health of workers who had direct exposure to oil and chemicals with those who did not, to understand if the sp…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Digital lifeline: new system aims to stop medical errors when patients move between hospitals
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a new digital platform designed to improve how patient information is shared when someone is transferred between different hospitals. The goal is to make sure doctors at the receiving hospital have all the necessary details to provide safe, continuous care. …
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Frozen tissue could help infertile men father children
Knowledge-focused OngoingThis study is testing whether frozen testicular tissue can be transplanted back into men to restore sperm production. Five healthy adult men who already have children will have small tissue samples frozen during routine surgery, then transplanted back under their skin months late…
Matched conditions: HEMATOLOGIC DISEASES
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC
-
Scientists seek clues in transplant Patients' tissues
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect tissue and blood samples from people who have received or donated bone marrow transplants for blood cancers like leukemia and lymphoma. Researchers will analyze these samples to better understand why complications happen and how to improve transplant su…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC